During the two past decades, atrial fibrillation (AF) has become a major public health problem. With 33.5 million patients worldwide, AF is the most common arrhythmia in adults. Accordingly, the $ 4.9 Bn AF device market is growing at 15.6% CAGR. Building upon 15+ years of research, Volta Medical has investigated a therapeutic product using data-driven AI approach for optimal real-time guidance during atrial fibrillation (AF) interventions. Our product has the potential to revolutionize AF interventions in drastically improving both procedural workflow and clinical outcomes. Notably, Volta’s product has been tested clinically with extremely promising results. Our first product is entirely ready for approval and does not need further development.
B2B
26 to 50
Funded
$3,150,000
Scaling Up
2016
Medical Devices
Life Sciences Tools & Services
Healthcare
N/A
Increase Efficiency
Analytics
Service
Yes
Active
Machine Learning
Machine Perception
N/A
Software
N/A
US Clinical & Technical Support Specialist
Remote, Remote
Responsable Affaires Réglementaires H/F
Marseille, Provence-Alpes-Côte d'Azur
AI/ML Professionals
Want to work at Volta Medical?
We can introduce you to the right person at Volta Medical
0
1
$38.01M
Company was founded 2016 and it took almost 7 years (Jan 2023) to raise first external round
Investors
Interested in researching Volta Medical?
We have plenty of data and we can help. Our deal sourcing platform can help you perform more research about Volta Medical
Potential Customers
Interested in what they do or partnership?
Learn more about how they work